Amdocs director Hortig granted 84,483 shares

Hortig Shimie reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hortig Shimie reported acquisition or exercise transactions in this Form 4 filing.

Amdocs Ltd director and officer Shimie Hortig received an equity grant as part of his compensation. On May 13, 2026, he was awarded 84,483 Amdocs ordinary shares at no purchase price, described as time-based restricted stock awards that vest over three years from the grant date.

After this grant, Hortig directly holds 181,696 ordinary shares. Because this is a share award rather than an open-market trade, it reflects routine equity compensation rather than a discretionary stock purchase or sale.

Insider Trade Summary

Grant/Award: 84,483 shares

Grant/Award 1 txn

Insider Hortig Shimie

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	84,483	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 181,696 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of time-based restricted stock awards which vest over 3 years from the grant date.

Key Figures

Shares granted: 84,483 shares Grant price per share: $0.00 per share Shares after transaction: 181,696 shares +2 more

5 metrics

Shares granted 84,483 shares Time-based restricted stock awards granted on May 13, 2026

Grant price per share $0.00 per share Reported acquisition price for the restricted stock grant

Shares after transaction 181,696 shares Total Amdocs ordinary shares directly held by Hortig after grant

Vesting period 3 years Time-based vesting schedule for restricted stock awards from grant date

Transactions acquiring shares 1 acquisition Single Form 4 equity grant coded as grant/award acquisition

Key Terms

time-based restricted stock awards, vest over 3 years, equity compensation, ordinary shares

4 terms

time-based restricted stock awards financial

"Represents a grant of time-based restricted stock awards which vest over 3 years from the grant date."

vest over 3 years financial

"time-based restricted stock awards which vest over 3 years from the grant date."

equity compensation financial

"he was awarded 84,483 Amdocs ordinary shares at no purchase price, described as time-based restricted stock awards"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

ordinary shares financial

"he was awarded 84,483 Amdocs ordinary shares at no purchase price"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Amdocs (DOX) director Shimie Hortig report in this Form 4 filing?

Shimie Hortig reported receiving a grant of 84,483 Amdocs ordinary shares as equity compensation. The shares are structured as time-based restricted stock awards that vest over three years, increasing his direct holdings to a total of 181,696 shares after the grant.

How many Amdocs (DOX) shares did Shimie Hortig acquire and at what price?

He acquired 84,483 ordinary shares of Amdocs at a reported price of $0.00 per share. This indicates a compensation-related grant, not an open-market purchase, and reflects stock-based pay rather than cash used to buy shares in the market.

How do Shimie Hortig’s Amdocs (DOX) holdings change after this transaction?

Following the grant, Hortig directly owns 181,696 Amdocs ordinary shares. The Form 4 shows this as his total direct position after receiving the 84,483-share restricted stock award, giving investors a clearer view of his current equity stake in the company.

What are the vesting terms of Shimie Hortig’s new Amdocs (DOX) restricted stock awards?

The filing states the 84,483-share grant consists of time-based restricted stock awards. These awards vest over three years from the grant date, meaning the shares become fully owned by Hortig gradually, subject to his continued service and the company’s vesting schedule.

Is Shimie Hortig’s Form 4 transaction a market buy or sell of Amdocs (DOX) shares?

No, this Form 4 does not report a market buy or sell. It reports an acquisition coded as a grant or award, with 84,483 shares received at $0.00 per share as compensation, rather than a discretionary open-market transaction involving cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 09:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hortig Shimie

(Last) (First) (Middle)

C/O AMDOCS INC

631 MARYVILLE CENTRE DRIVE, SUITE 200

(Street)

SAINT LOUIS MISSOURI 63141

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMDOCS LTD [ DOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	05/13/2026		A		84,483(1)	A	$0	181,696	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of time-based restricted stock awards which vest over 3 years from the grant date.

Remarks:

Director, President and Chief Executive Officer

	/s/ Shimie Hortig	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)